Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Post-operative Bowel Motility and Pain
NCT02790203Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jun 2016
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of celecoxib in postoperative ileus (POI), sponsored by Sheba Medical Center. Primary endpoint: Time to first flatus or bowel movement. Status: unknown.
02
Drugs
celecoxib
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT02790203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790203.